Increase of PCSK9 expression in diabetes promotes VEGFR2 ubiquitination to inhibit endothelial function and skin wound healing
Authors:
- 15 August 2024
- journal article
- research article
- Published by Springer Nature in Science China Life Sciences
- Vol. 67 (12) , 2635-2649
Abstract
Diabetic foot ulcers (DFUs) are a serious vascular disease. Currently, no effective methods are available for treating DFUs. Pro-protein convertase subtilisin/kexin type 9 (PCSK9) regulates lipid levels to promote atherosclerosis. However, the role of PCSK9 in DFUs remains unclear. In this study, we found that the expression of PCSK9 in endothelial cells (ECs) increased significantly under high glucose (HG) stimulation and in diabetic plasma and vessels. Specifically, PCSK9 promotes the E3 ubiquitin-protein ligase NEDD4 binding to vascular endothelial growth factor receptor 2 (VEGFR2), which led to the ubiquitination of VEGFR2, resulting in its degradation and downregulation in ECs. Furthermore, PCSK9 suppresses the expression and activation of AKT, endothelial nitric oxide synthase (eNOS), and ERK1/2, leading to decreased nitric oxide (NO) production and increased superoxide anion (O2._) generation, which impairs vascular endothelial function and angiogenesis. Importantly, using evolocumab to limit the increase in PCSK9 expression blocked the HG-induced inhibition of NO production and the increase in O2._ production, as well as inhibited the phosphorylation and expression of AKT, eNOS, and ERK1/2. Moreover, evolocumab improved vascular endothelial function and angiogenesis, and promoted wound healing in diabetes. Our findings suggest that targeting PCSK9 is a novel therapeutic approach for treating DFUs.Keywords
This publication has 43 references indexed in Scilit:
- Endothelial microparticles increase in mitral valve disease and impair mitral valve endothelial functionAmerican Journal of Physiology-Endocrinology and Metabolism, 2013
- The PCSK9 decadeJournal of Lipid Research, 2012
- Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levelsAtherosclerosis, 2012
- C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cellsDiabetologia, 2011
- Transforming growth factor-β2 promotes Snail-mediated endothelial–mesenchymal transition through convergence of Smad-dependent and Smad-independent signallingBiochemical Journal, 2011
- Sarpogrelate protects against high glucose-induced endothelial dysfunction and oxidative stressInternational Journal of Cardiology, 2011
- The oxidative stress of hyperglycemia and the inflammatory process in endothelial cellsThe Journal of Medical Investigation, 2009
- The Proprotein Convertase PCSK9 Induces the Degradation of Low Density Lipoprotein Receptor (LDLR) and Its Closest Family Members VLDLR and ApoER2Journal of Biological Chemistry, 2008
- Grb10 Prevents Nedd4-mediated Vascular Endothelial Growth Factor Receptor-2 DegradationJournal of Biological Chemistry, 2004
- p38 and ERK1/2 Coordinate Cellular Migration and Proliferation in Epithelial Wound HealingJournal of Biological Chemistry, 2003